Andrew J Stephenson

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Urol 1:90-6. 2004
  2. ncbi request reprint Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
    Andrew J Stephenson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:3973-8. 2006
  3. ncbi request reprint Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 94:1210-2. 2004
  4. pmc Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Natl Cancer Inst 98:715-7. 2006
  5. pmc Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 23:7005-12. 2005
  6. ncbi request reprint Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 25:5597-602. 2007
  7. ncbi request reprint Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 174:557-60; discussion 560. 2005
  8. ncbi request reprint Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Fernando J Bianco
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:448-53. 2005
  9. pmc Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram
    Ryan K Berglund
    Division of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 73:1098-103. 2009
  10. ncbi request reprint Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:8198-203. 2005

Detail Information

Publications36

  1. ncbi request reprint The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Urol 1:90-6. 2004
    ..To be successful, salvage EBRT should be administered at the earliest evidence of recurrent disease, once a rising PSA trend as been confirmed...
  2. ncbi request reprint Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
    Andrew J Stephenson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:3973-8. 2006
    ..Ten definitions of BCR were evaluated to identify the one that best explains metastatic progression...
  3. ncbi request reprint Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 94:1210-2. 2004
  4. pmc Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Natl Cancer Inst 98:715-7. 2006
    ..Thus, a new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy...
  5. pmc Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 23:7005-12. 2005
    ..We have updated the nomogram by extending the predictions to 10 years after RP and have enabled the nomogram predictions to be adjusted for the disease-free interval that a patient has maintained after RP...
  6. ncbi request reprint Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 25:5597-602. 2007
    ..3). CONCLUSION Patient selection factors have significantly improved the outcome of patients with CS IIA and IIB NSGCT without substantially increasing the proportion of patients exposed to chemotherapy...
  7. ncbi request reprint Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 174:557-60; discussion 560. 2005
    ....
  8. ncbi request reprint Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Fernando J Bianco
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:448-53. 2005
    ..We report the long-term cancer control associated with salvage RP in a consecutive cohort of patients and identify the variables associated with disease progression and cancer survival...
  9. pmc Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram
    Ryan K Berglund
    Division of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 73:1098-103. 2009
    ..5 ng/mL had outcomes different than predicted by a validated preoperative nomogram...
  10. ncbi request reprint Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:8198-203. 2005
    ..Salvage RP may favorably alter the natural history of biochemical recurrence after radiation therapy, but it must be instituted early in the course of recurrent disease to be effective...
  11. ncbi request reprint Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy
    Andrew J Stephenson
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Treat Options Oncol 5:357-65. 2004
    ..A long-term cure is possible for patients with locally recurrent prostate cancer after radiation therapy. Local salvage therapy must be instituted early to be successful in the course of progressive disease...
  12. ncbi request reprint Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Timothy A Masterson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 66:623-6. 2005
    ..To analyze the feasibility of neurovascular bundle (NVB) preservation and peripheral nerve grafting during salvage radical prostatectomy (RP) for radiorecurrent prostate cancer and analyze their effect on the recovery of potency...
  13. ncbi request reprint Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:2781-8. 2005
    ..Since 1999, our criteria have excluded patients with persistent postorchiectomy elevation of serum tumor markers (STM) or clinical stage (CS) IIB disease from RPLND...
  14. ncbi request reprint Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 172:2239-43. 2004
    ..We report the morbidity associated with salvage RP in 100 consecutive patients...
  15. ncbi request reprint Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 291:1325-32. 2004
    ..Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest risk of metastatic disease progression...
  16. ncbi request reprint Management of patients with low-stage nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Treat Options Oncol 6:367-77. 2005
    ....
  17. ncbi request reprint Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 176:1996-9; discussion 1999. 2006
    ..We reviewed our experience with adjunctive nephrectomy to assess the impact on cancer control and renal function...
  18. doi request reprint A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer
    Edouard J Trabulsi
    Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Urology 72:1298-302; discussion 1302-4. 2008
    ..We studied a group of patients undergoing ART by comparing them with a matched control group undergoing SRT after biochemical failure...
  19. pmc Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 104:290-8. 2005
    ..Gene expression profiling of prostate carcinoma offers an alternative means to distinguish aggressive tumor biology and may improve the accuracy of outcome prediction for patients with prostate carcinoma treated by radical prostatectomy...
  20. doi request reprint Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes
    Andrew J Stephenson
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
    BJU Int 102:1296-301. 2008
    ..Randomized trials are necessary to determine if the results achieved with LRC are equivalent to those of ORC...
  21. ncbi request reprint Impact of unnecessary exploratory laparotomy on the treatment of patients with metastatic germ cell tumor
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:1474-7. 2004
    ..In a cohort of patients who underwent exploratory laparotomy for unsuspected metastatic GCT we determined the impact of this surgery on morbidity, therapeutic delay and cancer therapy...
  22. doi request reprint Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 119:143-9. 2013
    ..Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial were used and simple decision analytic techniques were applied to compare different eligibility criteria for a screening trial...
  23. ncbi request reprint The role of retroperitoneal lymph node dissection in the management of testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Urol Oncol 22:225-33; discussion 234-5. 2004
    ..This article reviews the role of RPLND in the management of patients with NSGCT at all stages and its role in advanced seminoma...
  24. ncbi request reprint Nomograms for prostate cancer
    Andrew J Stephenson
    Section of Urologic Oncology, Glickman Urological Institute, Lerner College of Medicine, Cleveland, OH, USA
    BJU Int 98:39-46. 2006
  25. ncbi request reprint Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy
    Andrew J Stephenson
    Division of Urology, McGill University, Montreal, Quebec, Canada
    J Urol 172:58-62. 2004
    ..We characterized relapse patterns in patients with sporadic renal cell carcinoma (RCC) following radical and partial nephrectomy, and developed surveillance guidelines...
  26. doi request reprint Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400)
    Andrew J Stephenson
    Urology 72:719-20. 2008
  27. doi request reprint Prostate cancer volume at biopsy predicts clinically significant upgrading
    Fei Dong
    Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
    J Urol 179:896-900; discussion 900. 2008
    ..We identified clinical and pathological parameters that predict pathological upgrading in this population...
  28. ncbi request reprint Variations in PSA doubling time in patients with prostate cancer on "watchful waiting": value of short-term PSADT determinations
    Phillip L Ross
    Division of Urology, McGill University, Montreal, Quebec, Canada
    Urology 64:323-8. 2004
    ..Our aim was to determine the correlation between short-term PSADT measurements and long-term PSADT among men with prostate cancer on observation...
  29. pmc Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
    ..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
  30. ncbi request reprint Management of clinical stage I nonseminomatous germ cell testicular cancer
    Toni K Choueiri
    Department of Solid Tumor Oncology, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    Urol Clin North Am 34:137-48; abstract viii. 2007
    ..For patients at high risk for relapse and who are not candidates for surveillance, we believe the evidence supports RPLND over primary chemotherapy...
  31. ncbi request reprint Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy
    Matthew N Simmons
    Glickman Urological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue A100, Cleveland, OH 44195, USA
    Eur Urol 51:1175-84. 2007
    ..While a rising PSA level universally antedates metastatic progression and prostate cancer-specific mortality (PCSM), it is not a surrogate for these endpoints. Thus, the management of patients with BCR is controversial...
  32. ncbi request reprint Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer
    Andrew J Stephenson
    Department of Surgery Urology, McGill University, Montreal, Ontario, Canada
    Urology 59:652-6. 2002
    ..To evaluate the prostate-specific antigen (PSA) changes and the ability of PSA doubling time (PSADT) to predict disease progression in untreated patients with clinically localized prostate cancer...
  33. ncbi request reprint Screening for urologic malignancies in primary care: pros, cons, and recommendations
    Andrew J Stephenson
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 74:S6-14. 2007
    ....
  34. doi request reprint Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice
    Fei Dong
    School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
    J Urol 180:150-4; discussion 154. 2008
    ..In patients referred for biopsy following community screening we validated the Kattan and Steyerberg nomograms for predicting indolent disease in a contemporary urological practice...
  35. doi request reprint Systems pathology and predicting outcome after radical prostatectomy
    Eric A Klein
    J Clin Oncol 26:3916-7. 2008
  36. pmc Gene expression profiling predicts clinical outcome of prostate cancer
    Gennadi V Glinsky
    Sidney Kimmel Cancer Center, San Diego, California 92121, USA
    J Clin Invest 113:913-23. 2004
    ....